Natgenica Biotech

Natgenica Biotech leverages computational tools and AI-driven analysis to advance innovation in the drug discovery process. The company specializes in structure-based drug design, utilizing 3D structures of biological targets to identify molecules with optimal therapeutic binding properties. Additionally, their technical capabilities include molecular dynamics simulations to analyze atomic movements, network pharmacology for multi-target drug discovery, and virtual screening via molecular docking and high-throughput screening to predict interactions between drug candidates and proteins.

The company supports the development pipelines of academic institutions, pharmaceutical companies, and biotech startups by providing specialized computational research services. Their service offerings include target identification, ADMET property prediction, and preclinical validation support. Natgenica Biotech aims to accelerate therapeutic development by transforming research targets into viable drug candidates through a structured, multi-stage innovation pipeline led by a team of medicinal chemists and research scientists.